Opiophobia in Postsurgical Adults With Cancer

April 28, 2026 updated by: M.D. Anderson Cancer Center
To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer who were prescribed opioids for home use during the first week following hospital discharge for a surgical treatment of a malignancy.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • The Univerisity of Texas M. D. Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

MD Anderson Cancer Center

Description

Inclusion Criteria:

  1. Adult patient with cancer admitted for cancer-related surgery
  2. inpatient surgical hospital stay lasting at least 23 hours
  3. discharged home with a prescription for opioid analgesics
  4. able to read, speak, and consent in English.

Exclusion Criteria:

  1. Age less than 18 years
  2. not discharged with a prescription for opioid analgesia to manage pain
  3. individuals for whom there is documentation of inability to provide consent in the medical record.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Opiophobia in Postsurgical Adults
Participants that agree to take part in this study, partiicpants will have a virtual visit, via Zoom, about 7 days after you are discharged from the hospital. The visit will take about 20 minutes, and you will meet with a member of the research team to complete several questionnaires.
Other: 13-item Barriers Questionnaire (BQ-13)
Given by questionnaire
Other: Four-item Medication Adherence Questionnaire
Given by questionnaire
Other: 14-item Hospital Anxiety and Depression Scale (HADS)
Given by questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer.
Time Frame: Through study completion, an average of 1 year.
Use of opioids among a population of adults who underwent surgery for cancer.
Through study completion, an average of 1 year.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

M.D. Anderson Cancer Center

Collaborators

Sigma Theta Tau International

Investigators

  • Principal Investigator: Eileen Hacker, PHD,RN, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

July 31, 2024

First Submitted That Met QC Criteria

July 31, 2024

First Posted (Actual)

August 2, 2024

Study Record Updates

Last Update Posted (Actual)

May 4, 2026

Last Update Submitted That Met QC Criteria

April 28, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-0315
  • NCI-2024-06535 (Other Identifier: NCI-CTRP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on 13-item Barriers Questionnaire (BQ-13)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe